US group BAXTER INTERNATIONAL (hygiene and pharmaceutical products) plans to acquire a stake of between 20 and 25% in British PEPTIDE PHARMACEUTICALS for the sum of 130 pence per share. PEPTIDE is already negotiating with CANTAB PHARMACEUTICALS in order to sell it part of its shares at the price of 110 pence a share.